Literature DB >> 19709674

Distinct characteristics of amyloid deposits in early- and late-onset transthyretin Val30Met familial amyloid polyneuropathy.

Haruki Koike1, Yukio Ando, Mitsuharu Ueda, Yuichi Kawagashira, Masahiro Iijima, Junko Fujitake, Michiyuki Hayashi, Masahiko Yamamoto, Eiichiro Mukai, Tomohiko Nakamura, Masahisa Katsuno, Naoki Hattori, Gen Sobue.   

Abstract

Late-onset transthyretin Val30Met-associated familial amyloid polyneuropathy (FAP ATTR Val30Met) cases unrelated to endemic foci in Japan show different clinicopathological features from the conventional early-onset cases in endemic foci. We compared the characteristics of amyloid deposits in early-onset FAP ATTR Val30Met cases in endemic foci and late-onset cases in non-endemic areas. Amyloid deposits in three early-onset cases from endemic foci and five late-onset cases from non-endemic areas were systematically examined post-mortem. Amyloid deposits in early-onset cases were highly congophilic and showed strong apple-green birefringence with Congo red staining and had long, parallel fibrils in most organs. On the other hand, those in late-onset cases were generally weakly congophilic and showed faint apple-green birefringence with Congo red staining and had short, haphazard fibrils. In the renal glomus and adrenal gland of early-onset cases, the characteristics of amyloid deposits were similar to those observed in late-onset cases. Analysis of cardiac amyloid using surface enhanced desorption/ionization time-of-flight mass spectrometry indicated that most transthyretin (TTR) was variant in early-onset cases, while more than half was composed of wild-type TTR in late-onset cases. Although characteristics of amyloid deposits may differ among individual organs of respective cases, especially in early-onset cases, the pattern was distinct between early- and late-onset cases. Amyloid deposition in late-onset cases may be similar to that observed in senile systemic amyloidosis with wild-type TTR deposition, suggesting that aging may play an important role in these cases.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19709674     DOI: 10.1016/j.jns.2009.07.028

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  18 in total

Review 1.  Transthyretin Cardiac Amyloidosis in Black Americans.

Authors:  Keyur B Shah; Anit K Mankad; Adam Castano; Olakunle O Akinboboye; Phillip B Duncan; Icilma V Fergus; Mathew S Maurer
Journal:  Circ Heart Fail       Date:  2016-06       Impact factor: 8.790

2.  Age-dependent cognitive dysfunction in untreated hereditary transthyretin amyloidosis.

Authors:  Ana Martins da Silva; Sara Cavaco; Joana Fernandes; Raquel Samões; Cristina Alves; Márcio Cardoso; Jeffery W Kelly; Cecília Monteiro; Teresa Coelho
Journal:  J Neurol       Date:  2017-12-05       Impact factor: 4.849

3.  Late-Onset Hereditary Transthyretin Amyloidosis Val30Met in an Elderly Person in a Non-Endemic Area.

Authors:  Shun Wang; Jingping Sun; Qun Lu; Hao Li; Yun Zhang
Journal:  Int Med Case Rep J       Date:  2022-06-16

4.  Pathological changes long after liver transplantation in a familial amyloidotic polyneuropathy patient.

Authors:  Konen Obayashi; Mitsuharu Ueda; Toshinori Oshima; Satomi Kawahara; Yohei Misumi; Taro Yamashita; Hirofumi Jono; Masahide Yazaki; Fuyuki Kametani; Shu-ichi Ikeda; Yuki Ohya; Katsuhiro Asonuma; Yukihiro Inomata; Yukio Ando
Journal:  BMJ Case Rep       Date:  2012-08-18

5.  Diagnostic hallmarks and pitfalls in late-onset progressive transthyretin-related amyloid-neuropathy.

Authors:  Maike F Dohrn; Christoph Röcken; Jan L De Bleecker; Jean-Jacques Martin; Matthias Vorgerd; Peter Y Van den Bergh; Andreas Ferbert; Katrin Hinderhofer; J Michael Schröder; Joachim Weis; Jörg B Schulz; Kristl G Claeys
Journal:  J Neurol       Date:  2013-10-08       Impact factor: 4.849

Review 6.  Multidisciplinary Approaches for Transthyretin Amyloidosis.

Authors:  Haruki Koike; Takahiro Okumura; Toyoaki Murohara; Masahisa Katsuno
Journal:  Cardiol Ther       Date:  2021-06-04

7.  Variation in amount of wild-type transthyretin in different fibril and tissue types in ATTR amyloidosis.

Authors:  Elisabet Ihse; Ole B Suhr; Ulf Hellman; Per Westermark
Journal:  J Mol Med (Berl)       Date:  2010-11-25       Impact factor: 4.599

Review 8.  Novel approaches to diagnosis and management of hereditary transthyretin amyloidosis.

Authors:  Antonia Carroll; P James Dyck; Mamede de Carvalho; Marina Kennerson; Mary M Reilly; Matthew C Kiernan; Steve Vucic
Journal:  J Neurol Neurosurg Psychiatry       Date:  2022-03-07       Impact factor: 13.654

Review 9.  Guideline of transthyretin-related hereditary amyloidosis for clinicians.

Authors:  Yukio Ando; Teresa Coelho; John L Berk; Márcia Waddington Cruz; Bo-Göran Ericzon; Shu-ichi Ikeda; W David Lewis; Laura Obici; Violaine Planté-Bordeneuve; Claudio Rapezzi; Gerard Said; Fabrizio Salvi
Journal:  Orphanet J Rare Dis       Date:  2013-02-20       Impact factor: 4.123

10.  A Review of Tafamidis for the Treatment of Transthyretin-Related Amyloidosis.

Authors:  Márcia Waddington Cruz; Merril D Benson
Journal:  Neurol Ther       Date:  2015-08-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.